The success of COVID vaccine development highlights the importance of private sector innovation. Yet, President Biden and Congress are launching a policy attack that could prevent future medical innovation.
Lowering drug costs by importing from Canada.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Government negotiations of prices for Medicare prescription drugs could endanger choice and savings for seniors.